Reanalysis and Reclassification of Diagnostic Exome Sequencing
Explore the evolving landscape of diagnostic exome sequencing, focusing on reclassification reasons, rates, and how new gene-disease discoveries enhance diagnostic success in Mendelian diseases.
Interpreting Genetic Testing Results for Non-Genetics Providers
Guidance for non-genetics providers on interpreting genetic test results, considering patient history, and utilizing resources for result interpretation and patient care.
Applying Somatic Germline Testing for Lynch Syndrome
Explore paired tumor/germline testing for Lynch syndrome, its benefits, and comparison to other strategies. Learn to navigate discordant results and understand current literature on somatic genetic testing.
Ambry's Translational Genomics Lab: Understanding Variants of Uncertain Significance
Overview of Ambry's Translational Genomics Lab services for assessing variants of uncertain significance, focusing on RNA protocol for splicing variants to improve diagnostic yield and guide patient treatment.
Testing Your Patient - DTC vs Single Gene vs Panel vs Exome
Explore differences between direct-to-consumer and clinical genetic testing, learn when each is appropriate, and gain insights on advising patients about genetic test results.
Exome Testing - An Evidence-Based Approach to Accurate Diagnosis
Explore Ambry's evidence-based approach to clinical exome sequencing, including their proprietary scoring system for linking genes to diseases, leading to higher diagnostic yields and improved patient care.
The Truth About Next Generation Sequencing (NGS)
Explore Ambry's findings on the necessity of Sanger confirmation alongside NGS for optimal genetic testing accuracy, and learn about potential consequences of less rigorous procedures.
Cardiovascular Genetic Testing Practices Around the World - Inherited Arrhythmias Series, Part 3
Explore global approaches to cardiovascular genetic testing for inherited arrhythmias, comparing diagnostic processes in Canada, Europe, and the US with insights from experts.
Genetic Testing for Neurodevelopmental Disorders
Explore genetic testing methods for neurodevelopmental disorders, including microarray, single syndrome, multi-gene panels, and diagnostic exome sequencing, to aid in diagnosing conditions like autism and epilepsy.
Clinical Diagnostic Exome Sequencing - Addressing Clinical Utility and Cost-Effectiveness
Explore clinical diagnostic exome sequencing's utility and cost-effectiveness with experts discussing its role in the diagnostic process and impact on patient care.
Genetic Testing in Hereditary Hemorrhagic Telangiectasia
Explore genetic testing for Hereditary Hemorrhagic Telangiectasia with expert Katie Wusik. Learn about clinical diagnosis, recent research, and the impact on patients and families.
Evaluation and Genetic Testing for Sudden Death
Comprehensive overview of sudden death evaluation, covering team roles, autopsy tools, sample types, and potential causes. Equips healthcare professionals with essential knowledge for case investigation.
Cystic Fibrosis Newborn Screening - What You Need to Know
Comprehensive overview of cystic fibrosis newborn screening, covering methodology, process, and implications for positive results. Presented by an expert from the California Department of Public Health.
Clinical and Management Implications of Exome Sequencing
Explore the clinical and management implications of diagnostic exome sequencing, examining current scientific evidence and its impact on genetic testing practices.
Genetic Testing for Young High-Risk Women
Empowering young high-risk women through genetic testing, featuring insights on inherited gene mutations and personal experiences from Bright Pink members.
At-Home Genetic Testing: Helpful or Harmful?
Explore the implications of at-home genetic testing kits with experts, discussing their accuracy, benefits, and potential risks in this informative public discussion event.
Evidence Needed to Support Genomic Population Screening - Session 5
Experts discuss population genomic screening, covering value propositions, cost-effectiveness, implementation experiences, and specific case studies like APOL1 screening, to inform future research and clinical practice.
Genomic Screening Technologies: Approaches, Challenges, and Considerations - Session 2
Explore genomic screening technologies, their applications in public health, and challenges in implementation. Experts discuss technical approaches, newborn screening, and factors for calculating screening effectiveness.
Logistics of Population Screening in Genomic Medicine - Session 3
Explores challenges and opportunities in population genomic screening, addressing readiness, timing, underrepresented populations, provider training, and patient education for improved healthcare outcomes.
Obstacles to Genomic Medicine and Population Screening - Session 6
Explore challenges in genomic screening: payer reluctance, data sharing complexities, EHR integration, and demonstrating health benefits. Experts discuss obstacles and potential solutions.
Genomic Medicine XV - Research Directions, Summary and Next Steps
Explore the latest developments in genomic medicine, focusing on population screening, barriers, opportunities, clinical impact, technologies, costs, and future research directions.